HRMYHarmony Biosciences Holdings, Inc.

$2B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$81M+77.0% YoY

Gross Profit

$66M81.9% margin

Operating Income

$21M26.1% margin

Net Income

-$10M-11.9% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

+9.4%

Cash Flow

Operating Cash Flow

$30M

Free Cash Flow

$30M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$391M

Total Liabilities

$239M

Stockholders' Equity

$152M

Cash & Equivalents

$190M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$81M	$46M	+77.0%
Gross Profit	$66M	$38M	+75.3%
Operating Income	$21M	$10M	+102.8%
Net Income	-$10M	$2M	-603.9%

HRMY Q3 2021 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena